Susquehanna International Group’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,842
Closed -$14.5K 14186
2025
Q4
$14.5K Buy
+2,842
New +$21.6K ﹤0.01% 12012
2025
Q3
Sell
-833
Closed -$12.7K 14009
2025
Q2
$12.7K Buy
+833
New +$9.18K ﹤0.01% 12385
2025
Q1
Sell
-566
Closed -$6.79K 13542
2024
Q4
$6.79K Sell
566
-2,265
-80% -$30.4K ﹤0.01% 11999
2024
Q3
$34K Buy
+2,831
New +$36.4K ﹤0.01% 11502
2024
Q2
Sell
-2,504
Closed -$36.7K 13320
2024
Q1
$37.9K Buy
+2,504
New +$49.1K ﹤0.01% 11643
2023
Q2
Sell
-5,645
Closed -$186K 13232
2023
Q1
$216K Buy
5,645
+3,236
+134% +$135K ﹤0.01% 10439
2022
Q4
$117K Sell
2,409
-1,324
-35% -$51.4K ﹤0.01% 10796
2022
Q3
$102K Buy
3,733
+455
+14% +$17.2K ﹤0.01% 11692
2022
Q2
$134K Buy
3,278
+31
+1% +$1.56K ﹤0.01% 11170
2022
Q1
$195K Sell
3,247
-601
-16% -$34.1K ﹤0.01% 11268
2021
Q4
$242K Buy
3,848
+319
+9% +$21.8K ﹤0.01% 11023
2021
Q3
$219K Buy
3,529
+777
+28% +$49.2K ﹤0.01% 11294
2021
Q2
$181K Sell
2,752
-536
-16% -$36.3K ﹤0.01% 11693
2021
Q1
$249K Buy
3,288
+1,996
+154% +$171K ﹤0.01% 10995
2020
Q4
$101K Buy
1,292
+289
+29% +$19.9K ﹤0.01% 10492
2020
Q3
$64K Buy
+1,003
New +$68.2K ﹤0.01% 10128
2019
Q1
Sell
-1,470
Closed -$53K 9920
2018
Q4
$53K Buy
+1,470
New +$70K ﹤0.01% 8466

Other funds holding VNRX

Susquehanna International Group's VNRX Position: Q1 2026 in Review

Susquehanna International Group sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 2,842 shares — an estimated $14.5K sold.

Susquehanna International Group first reported a position in VNRX in Q4 2018 and held it in 17 quarters. The position peaked at $249K in Q1 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Susquehanna International Group reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 2,842 VolitionRx Ltd shares in Q1 2026, an estimated $14.5K.
  • Susquehanna International Group first reported a position in VolitionRx Ltd in Q4 2018 and held it in 17 quarters.
  • Susquehanna International Group's VolitionRx Ltd position peaked at $249K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.